Insider · CIK 0001602459

Szekeres David Leslie

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001602459

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-18	GRIGRI Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+39.9K sh	—	—	39,897
2025-08-26	GRIGRI Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.3K sh	—	—	10,276
2025-08-13	GRIGRI Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,545 sh	—	—	7,545
2025-01-23	GRIGRI Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+51.9K sh	$0.69	+$35.6K	51,937
2023-08-10	GRIGRI Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34.5K sh	$2.90	+$100K	34,483
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,250 sh	—	—	31,202
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+4,564 sh	—	—	35,766
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−2,012 sh	$1.31	−$2,635.72	33,754
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,250 sh	—	—	6,250
2023-07-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−4,564 sh	—	—	23,372
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,250 sh	—	—	27,400
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+4,564 sh	—	—	31,964
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−2,012 sh	$2.88	−$5,794.56	29,952
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,250 sh	—	—	7,500
2023-04-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−4,564 sh	—	—	27,936
2023-01-18	HRTXHERON THERAPEUTICS, INC. /DE/ · Performance Stock UnitsA Award	EVP, Chief Operating Officer	AAward	+49.8K sh	—	—	49,788
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,250 sh	—	—	23,598
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+4,564 sh	—	—	28,162
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−2,012 sh	$3.17	−$6,378.04	26,150
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,250 sh	—	—	8,750
2023-01-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−4,564 sh	—	—	32,500
2022-10-31	HRTXHERON THERAPEUTICS, INC. /DE/J Other	EVP, Chief Operating Officer	JOther	+1,654 sh	$3.27	+$5,412.715	22,348
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,250 sh	—	—	18,142
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+4,564 sh	—	—	22,706
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−2,012 sh	$3.76	−$7,565.12	20,694
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,250 sh	—	—	10,000
2022-10-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−4,564 sh	—	—	37,064
2022-07-25	HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)A Award	EVP, Chief Operating Officer	AAward	+166K sh	—	—	165,961
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,250 sh	—	—	14,340
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+4,564 sh	—	—	18,904
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−2,012 sh	$3.01	−$6,056.12	16,892
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,250 sh	—	—	11,250
2022-07-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−4,564 sh	—	—	41,628
2022-04-29	HRTXHERON THERAPEUTICS, INC. /DE/J Other	EVP, Chief Operating Officer	JOther	+1,505 sh	$3.84	+$5,782.21	13,090
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,250 sh	—	—	9,033
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+4,564 sh	—	—	13,597
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−2,012 sh	$6.07	−$12.2K	11,585
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,250 sh	—	—	12,500
2022-04-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−4,564 sh	—	—	46,192
2022-01-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,250 sh	—	—	5,231
2022-01-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+4,564 sh	—	—	9,795
2022-01-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−2,012 sh	$8.30	−$16.7K	7,783
2022-01-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,250 sh	—	—	13,750
2022-01-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−4,564 sh	—	—	50,756
2021-10-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,250 sh	—	—	4,414
2021-10-13	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Operating Officer	FTax Payment	−433 sh	$10.55	−$4,568.15	3,981
2021-10-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,250 sh	—	—	15,000
2021-10-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Employee Stock Option (Right to Buy)A Award	EVP, Chief Operating Officer	AAward	+92.2K sh	—	—	92,200
2021-10-13	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsA Award	EVP, Chief Operating Officer	AAward	+55.3K sh	—	—	55,320
2021-07-13	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,250 sh	—	—	3,597

Recent filings

Accepted (ET)
Sep 224
Szekeres David Leslie0001602459-25-000004
SEC(opens sec.gov)
Aug 274
Szekeres David Leslie0001824293-25-000143
SEC(opens sec.gov)
Aug 144
Szekeres David Leslie0001824293-25-000116
SEC(opens sec.gov)
Jan 244
Szekeres David Leslie0001824293-25-000030
SEC(opens sec.gov)
Aug 144
Szekeres David Leslie0001824293-23-000156
SEC(opens sec.gov)
Jul 174
Szekeres David Leslie0001209191-23-042480
SEC(opens sec.gov)
Apr 174
Szekeres David Leslie0001209191-23-024500
SEC(opens sec.gov)
Jan 204
Szekeres David Leslie0001209191-23-004304
SEC(opens sec.gov)
Jan 174
Szekeres David Leslie0001209191-23-003564
SEC(opens sec.gov)

Companies

Address

3580 CARMEL MOUNTAIN ROAD, SUITE 200

SAN DIEGO, CA, 92130